Momentum is building for carrying out more phase III comparative trials in gastric cancer, with some using biomarker-based patient selection strategies. In this Review, the authors discuss representative molecular and clinical dimensions of gastric cancer, the fourth most common cancer in men and fifth most common cancer in women.
- Roopma Wadhwa
- Shumei Song
- Jaffer A. Ajani